Search results

Slaughter and May is advising ME Group International plc in connection with its strategic options review Slaughter and May is advising ME Group International plc in connection with its strategic options review Slaughter and May is advising on the proposed privatisation of Beijing Properties (Holdings) Limited by way of a scheme of arrangement Slaughter and May is advising Spectris on a recommended cash acquisition by funds managed and/or advised by Advent International, L.P. Slaughter and May is advising Spectris on a recommended cash acquisition by funds managed and/or advised by Advent International, L.P. Slaughter and May is advising Song Capital on a €702.5 million secured financing Slaughter and May is advising Song Capital on a €702.5 million secured financing Slaughter and May is advising Crédit Agricole as Bookrunner on c.€700m of facilities made available to Nido Living Slaughter and May is advising Crédit Agricole as Bookrunner on c.€700m of facilities made available to Nido Living Slaughter and May advised MTR on the largest-ever USD corporate subordinated perpetual securities issuance in Asia (ex-Japan) Slaughter and May advised MTR on the largest-ever USD corporate subordinated perpetual securities issuance in Asia (ex-Japan) Slaughter and May advised Derwent London PLC on its £250m bond issue Slaughter and May advised Derwent London PLC on its £250m bond issue Slaughter and May is advising Spectris on a recommended cash acquisition by funds advised by Kohlberg Kravis Roberts & Co. L.P. Slaughter and May is advising Spectris on a recommended cash acquisition by funds advised by Kohlberg Kravis Roberts & Co. L.P. Slaughter and May is advising Reinet, CVC, ADIA and HPS on the sale of Pension Insurance Corporation to Athora Slaughter and May is advising Reinet, CVC, ADIA and HPS on the sale of Pension Insurance Corporation to Athora Slaughter and May advised Dojo on its $190 million equity investment from Vitruvian Partners Slaughter and May advised Dojo, the UK-based payments technology provider, on its $190 million equity investment from Vitruvian Partners.